← Leaderboards
Edward Roberts
Scripps Research Institute, The
$6,084,768
Attributed
$7,951,761
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–15$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,951,761 · 4
By mechanism
U01$5,416,688 · 2
UH2$1,390,332 · 1
R01$1,144,741 · 1
Top collaborators
- Michael Darin Cameron4 shared
- Thomas D Bannister1 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Michael Darin Cameron$4,952,970
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroReceptorAffinityPre-ClinicalRattusIn VivoPropertyCharacteristicsCellsLeadBaseAnimal ModelPharmacologyProgramsPharmaceutical PreparationsSiteNeuraxisNeuropeptidesAreaMolecular WeightRodentMedicineAgonistSmall Molecule
Grant awards (12)
Discovery of non-addictive KOR antagonists for migraine prophylaxis$1,390,332
UH2 · FY2015 · NS · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$773,574
U01 · FY2013 · AA
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$862,395
U01 · FY2012 · AA
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$888,550
U01 · FY2011 · AA
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain$1
U01 · FY2011 · NS · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$907,100
U01 · FY2010 · AA
Design & Synthesis of Novel CNS-Active Oxytocin and Vasopressin Receptor Ligands$560,535
R01 · FY2010 · MH · contact PI
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain$1
U01 · FY2010 · NS · contact PI
Design & Synthesis of Novel CNS-Active Oxytocin and Vasopressin Receptor Ligands$584,206
R01 · FY2009 · MH · contact PI
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain$1
U01 · FY2009 · NS · contact PI
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain$919,487
U01 · FY2008 · NS · contact PI
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain$1,065,579
U01 · FY2007 · NS · contact PI